RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors

We compare differences in gene expression induced after treating MCF7-xenograft mice with either ribociclib, palbociclib, or abemacicilb daily for 4 days. Overall design: Mice were engrafted with MCF7 cells in each flank and allowed to grow to ~300 mm3. The animals were then randomly assigned to treatment groups, and treated daily for four days with ribociclib (150 mg/kg), palbociclib (150 mg/kg), abemaciclib (25, 75, 100, 125, or 150 mg/kg), or vehicle control (0.5% (w/v)